SillaJen, Inc. Logo

SillaJen, Inc.

215600.KQ

(0.0)
Stock Price

2.525,00 KRW

-15.66% ROA

-28.88% ROE

-12.5x PER

Market Cap.

378.239.460.000,00 KRW

6.92% DER

0% Yield

-646.53% NPM

SillaJen, Inc. Stock Analysis

SillaJen, Inc. Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

SillaJen, Inc. Fundamental Stock Analysis
# Analysis Rating
1 ROE

Unidentified ROE

2 ROA

Unidentified ROA

3 PBV

Unidentified ROA

4 DER

Unidentified DER

5 Revenue Growth

Company's revenue has stayed stagnant, showing no signs of improvement and making it a less favorable choice.

6 Net Profit Growth

Despite the passage of five years, this company's net profit has not shown any improvement, highlighting a lack of growth and making it a less appealing investment prospect.

7 Assets Growth

Company's revenue has stayed stagnant, showing no signs of improvement and making it a less favorable choice.

8 Graham Number

Unidentified Graham Number

9 Dividend Growth

The company's dividend growth has shown no improvement in the past three years, making it a less attractive investment option for those seeking increasing returns.

10 Dividend

No dividends from the company in the past three years raises doubts about its profitability for shareholders.

11 Buffet Intrinsic Value

Based on Warren Buffett's formula, the company's stock seems overpriced (0), indicating a potential drawback for investors as its market price exceeds its estimated intrinsic value.

SillaJen, Inc. Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

SillaJen, Inc. Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Hold
2 MACD Buy
3 RSI Hold
4 Stoch RSI Sell

SillaJen, Inc. Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

SillaJen, Inc. Revenue
Year Revenue Growth
2014 2.085.870.730
2015 1.809.856.651 -15.25%
2016 5.292.317.531 65.8%
2017 6.864.849.467 22.91%
2018 7.712.024.811 10.99%
2019 9.068.581.313 14.96%
2020 1.669.716.316 -443.12%
2021 254.362.816 -556.43%
2022 5.013.362.991 94.93%
2023 6.873.691.680 27.06%
2023 3.939.558.696 -74.48%
2024 3.227.773.036 -22.05%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

SillaJen, Inc. Research and Development Expenses
Year Research and Development Expenses Growth
2014 0
2015 0 0%
2016 0 0%
2017 0 0%
2018 0 0%
2019 0 0%
2020 0 0%
2021 0 0%
2022 9.411.201.000 100%
2023 0 0%
2023 10.192.982.000 100%
2024 12.539.964.000 18.72%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

SillaJen, Inc. General and Administrative Expenses
Year General and Administrative Expenses Growth
2014 0
2015 14.327.491.090 100%
2016 17.114.475.130 16.28%
2017 21.659.609.230 20.98%
2018 28.006.607.660 22.66%
2019 28.131.758.470 0.44%
2020 17.289.641.000 -62.71%
2021 1.654.845.000 -944.79%
2022 2.259.811.000 26.77%
2023 0 0%
2023 2.497.351.000 100%
2024 3.113.096.000 19.78%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

SillaJen, Inc. EBITDA
Year EBITDA Growth
2014 -12.863.530.310
2015 -20.404.029.440 36.96%
2016 -43.143.190.600 52.71%
2017 -46.891.949.760 7.99%
2018 -55.739.867.850 15.87%
2019 -55.148.519.420 -1.07%
2020 -32.933.414.420 -67.45%
2021 -19.238.670.380 -71.18%
2022 -23.248.448.190 17.25%
2023 -21.496.420.280 -8.15%
2023 -20.326.240.900 -5.76%
2024 -25.587.255.680 20.56%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

SillaJen, Inc. Gross Profit
Year Gross Profit Growth
2014 2.085.870.730
2015 -20.922.885.349 109.97%
2016 -42.471.287.469 50.74%
2017 -45.213.333.533 6.06%
2018 -52.386.556.189 13.69%
2019 -52.302.662.422 -0.16%
2020 -17.729.843.311 -195%
2021 -17.289.899.741 -2.54%
2022 -18.766.595.825 7.87%
2023 6.873.691.680 373.02%
2023 -16.359.764.610 142.02%
2024 -18.919.206.964 13.53%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

SillaJen, Inc. Net Profit
Year Net Profit Growth
2014 -2.477.889.950
2015 -55.853.786.856 95.56%
2016 -74.037.961.067 24.56%
2017 -57.020.831.505 -29.84%
2018 -56.236.181.150 -1.4%
2019 -113.199.973.347 50.32%
2020 -47.824.888.873 -136.7%
2021 -15.305.323.904 -212.47%
2022 -24.593.128.293 37.77%
2023 -21.347.981.040 -15.2%
2023 -20.369.238.698 -4.81%
2024 -26.830.118.404 24.08%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

SillaJen, Inc. Earning per Share (EPS)
Year Earning per Share (EPS) Growth
2014 -116
2015 -907 87.2%
2016 -1.452 37.6%
2017 -795 -82.64%
2018 -737 -7.87%
2019 -1.481 50.24%
2020 -618 -139.64%
2021 -168 -270.06%
2022 -221 24.43%
2023 -208 -6.25%
2023 -183 -13.66%
2024 -256 28.52%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

SillaJen, Inc. Free Cashflow
Year Free Cashflow Growth
2014 -17.548.260.319
2015 -25.524.965.915 31.25%
2016 -45.983.934.486 44.49%
2017 -40.866.446.580 -12.52%
2018 -49.612.807.490 17.63%
2019 -57.699.272.072 14.01%
2020 -43.027.861.850 -34.1%
2021 -9.777.235.609 -340.08%
2022 -41.594.532.572 76.49%
2023 -4.499.447.840 -824.44%
2023 -17.378.236.431 74.11%
2024 -5.859.226.108 -196.6%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

SillaJen, Inc. Operating Cashflow
Year Operating Cashflow Growth
2014 -17.126.243.559
2015 -22.387.351.251 23.5%
2016 -45.613.818.660 50.92%
2017 -40.074.633.685 -13.82%
2018 -49.315.767.188 18.74%
2019 -56.855.416.000 13.26%
2020 -42.927.145.098 -32.45%
2021 -9.706.479.197 -342.25%
2022 -22.139.955.054 56.16%
2023 -4.461.219.480 -396.28%
2023 -17.017.385.203 73.78%
2024 -5.733.024.417 -196.83%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

SillaJen, Inc. Capital Expenditure
Year Capital Expenditure Growth
2014 422.016.760
2015 3.137.614.664 86.55%
2016 370.115.826 -747.74%
2017 791.812.895 53.26%
2018 297.040.302 -166.57%
2019 843.856.072 64.8%
2020 100.716.752 -737.85%
2021 70.756.412 -42.34%
2022 19.454.577.518 99.64%
2023 38.228.360 -50790.43%
2023 360.851.228 89.41%
2024 126.201.691 -185.93%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

SillaJen, Inc. Equity
Year Equity Growth
2014 47.356.704.800
2015 86.935.317.759 45.53%
2016 207.971.487.369 58.2%
2017 201.947.240.357 -2.98%
2018 165.087.905.837 -22.33%
2019 60.992.529.193 -170.67%
2020 22.879.743.194 -166.58%
2021 108.048.080.787 78.82%
2022 78.939.492.624 -36.87%
2023 57.313.962.974 -37.73%
2023 63.071.966.160 9.13%
2024 146.746.437.007 57.02%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

SillaJen, Inc. Assets
Year Assets Growth
2014 171.683.382.950
2015 153.027.747.429 -12.19%
2016 284.127.918.504 46.14%
2017 234.954.188.168 -20.93%
2018 193.193.204.355 -21.62%
2019 69.745.029.861 -177%
2020 47.423.224.925 -47.07%
2021 134.827.627.589 64.83%
2022 103.446.061.546 -30.34%
2023 76.714.902.109 -34.84%
2023 84.359.197.660 9.06%
2024 166.670.409.005 49.39%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

SillaJen, Inc. Liabilities
Year Liabilities Growth
2014 124.326.678.150
2015 66.092.429.670 -88.11%
2016 76.156.431.135 13.21%
2017 33.006.947.811 -130.73%
2018 28.105.298.518 -17.44%
2019 8.752.500.668 -221.11%
2020 24.543.481.731 64.34%
2021 26.779.546.803 8.35%
2022 24.506.568.922 -9.27%
2023 19.400.939.135 -26.32%
2023 21.287.231.500 8.86%
2024 19.923.971.998 -6.84%

SillaJen, Inc. Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
34.08
Net Income per Share
-220.32
Price to Earning Ratio
-12.5x
Price To Sales Ratio
106.02x
POCF Ratio
-13.91
PFCF Ratio
-18.05
Price to Book Ratio
1.97
EV to Sales
78.42
EV Over EBITDA
-12.51
EV to Operating CashFlow
-13.49
EV to FreeCashFlow
-13.35
Earnings Yield
-0.08
FreeCashFlow Yield
-0.06
Market Cap
378,24 Bil.
Enterprise Value
279,76 Bil.
Graham Number
2636.06
Graham NetNet
1032.83

Income Statement Metrics

Net Income per Share
-220.32
Income Quality
0.9
ROE
-0.29
Return On Assets
-0.14
Return On Capital Employed
-0.16
Net Income per EBT
1
EBT Per Ebit
0.99
Ebit per Revenue
-6.54
Effective Tax Rate
0

Margins

Sales, General, & Administrative to Revenue
-1.22
Research & Developement to Revenue
3.17
Stock Based Compensation to Revenue
0.08
Gross Profit Margin
-4.93
Operating Profit Margin
-6.54
Pretax Profit Margin
-6.49
Net Profit Margin
-6.47

Dividends

Dividend Yield
0
Dividend Yield %
0
Payout Ratio
0
Dividend Per Share
0

Operating Metrics

Operating Cashflow per Share
-198.08
Free CashFlow per Share
-200.13
Capex to Operating CashFlow
-0.01
Capex to Revenue
0.06
Capex to Depreciation
0.22
Return on Invested Capital
-0.15
Return on Tangible Assets
-0.16
Days Sales Outstanding
98
Days Payables Outstanding
0
Days of Inventory on Hand
23.15
Receivables Turnover
3.72
Payables Turnover
0
Inventory Turnover
15.77
Capex per Share
2.04

Balance Sheet

Cash per Share
1.209,89
Book Value per Share
1.401,75
Tangible Book Value per Share
1216.44
Shareholders Equity per Share
1401.75
Interest Debt per Share
113.75
Debt to Equity
0.07
Debt to Assets
0.06
Net Debt to EBITDA
4.4
Current Ratio
7.47
Tangible Asset Value
127,35 Bil.
Net Current Asset Value
123,38 Bil.
Invested Capital
145614971759
Working Capital
124,12 Bil.
Intangibles to Total Assets
0.12
Average Receivables
0,93 Bil.
Average Payables
0,00 Bil.
Average Inventory
1390507833
Debt to Market Cap
0.03

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

SillaJen, Inc. Dividends
Year Dividends Growth

SillaJen, Inc. Profile

About SillaJen, Inc.

SillaJen, Inc. engages in the development and commercialization of oncolytic immunotherapy products. The company's lead product is Pexa-Vec, which is in Phase II clinical trial for the treatment of advanced liver cancer. It also develops JX-970 for the treatment of tumor tissues; and JX-900 is a series of modified vaccinia vaccine. The company was founded in 2006 and is headquartered in Seoul, South Korea.

CEO
Mr. Jaekyung Kim
Employee
37
Address
O2 Tower
Seoul, 07325

SillaJen, Inc. Executives & BODs

SillaJen, Inc. Executives & BODs
# Name Age
1 Chan Kwon Hyuk M.D., Ph.D.
Chief Medical Officer
70
2 Mr. Jeongseok Lee
Executive Officer
70
3 Mr. Eun-Ki Min
Chief Accounting Officer and Executive Director
70
4 Mr. Jaekyung Kim
Chief Executive Officer & Chairman of the Board
70
5 Mee Yang Kyung Ph.D.
Head of R&D Strategic Planning
70
6 Mr. Jaejeong Lee
Executive Officer
70
7 Suk Song Myung
Chief Financial Officer
70

SillaJen, Inc. Competitors